 |
Corporate News
05-Jun-24
|
|
|
|
|
|
|
|
|
|
|
|
Lupin acquires Sanofi brands - Aarane™ and Nalcrom™
|
|
|
|
|
|
|
|
Lupin today announced that its European hub entity, Lupin Atlantis Holdings SA, has completed the acquisition of two well-known
brands, Aarane™ in Germany and Nalcrom™ in Canada and the Netherlands, along with the associated trademark rights, from Sanofi.
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas, where the company has a leading position, with high-quality products that are innovative or unique in the market.
This acquisition will enhance Lupin's Respiratory business in Germany, by aiding in the expansion of the newly established franchise, following the introduction of Luforbec™.
|
|
|
|
Previous News |
Lupin’s Pithampur facility completes USFDA inspection with 3 observations
(
Hot Pursuit
-
28-Sep-24
14:54
)
|
|
|
Lupin's Pithampur Unit-1 API and finished product facility concludes USFDA inspection
(
Corporate News
-
28-Sep-24
10:40
)
|
|
|
Lupin allots 5,893 equity shares under ESOP
(
Corporate News
-
20-Sep-24
12:42
)
|
|
|
Lupin joins hand with Takeda to Launch Vonoprazan Tablets in India
(
Hot Pursuit
-
18-Sep-24
14:50
)
|
|
|
Lupin enters into patent license agreement with Takeda
(
Corporate News
-
18-Sep-24
13:43
)
|
|
|
Lupin gains on inking pact to acquire 43% stake in Sunsure Solarpark
(
Hot Pursuit
-
12-Sep-24
12:26
)
|
|
|
Lupin Ltd soars 1.38%, up for third straight session
(
Hot Pursuit
-
05-Sep-24
13:05
)
|
|
|
Lupin hits life high on launching overactive bladder drug in US
(
Hot Pursuit
-
04-Sep-24
15:15
)
|
|
|
Lupin launches Mirabegron Extended-Release Tablets in US
(
Corporate News
-
04-Sep-24
15:07
)
|
|
|
Lupin allots 1.21 lakh equity shares under ESOP
(
Corporate News
-
28-Aug-24
18:53
)
|
|
|
Lupin Ltd up for third consecutive session
(
Hot Pursuit
-
28-Aug-24
13:05
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|